Literature DB >> 21738013

Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.

James T Mascarello1, Betsy Hirsch, Hutton M Kearney, Rhett P Ketterling, Susan B Olson, Denise I Quigley, Kathleen W Rao, James H Tepperberg, Karen D Tsuchiya, Anne E Wiktor.   

Abstract

This updated Section E9 has been incorporated into and supersedes the previous Section E9 in Section E: Clinical Cytogenetics of the 2008 Edition (Revised 02/2007) American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories. This section deals specifically with the standards and guidelines applicable to fluorescence in situ hybridization analysis.

Entities:  

Mesh：

Year:  2011        PMID： 21738013     DOI： 10.1097/GIM.0b013e3182227295

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


  21 in total

1.  Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping.

Authors:  George Papaxoinis; Vassiliki Kotoula; Eleni Giannoulatou; Georgia-Angeliki Koliou; Vasilios Karavasilis; Sotirios Lakis; Andreas Koureas; Mattheos Bobos; Elpida Chalaralambous; Emily Daskalaki; Kyriakos Chatzopoulos; George Tsironis; Elisavet Pazarli; Sofia Chrisafi; Epaminontas Samantas; Ioannis G Kaklamanos; Ioannis Varthalitis; Athina Konstantara; Konstantinos N Syrigos; George Pentheroudakis; Dimitrios Pectasides; George Fountzilas
Journal:  Med Oncol       Date:  2018-05-31       Impact factor: 3.064

2.  Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.

Authors:  Zhenya Tang; Jianjun Zhang; Xinyan Lu; Wei Wang; Hui Chen; Melissa K Robinson; Joanne Cheng; Guilin Tang; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2017-09-15       Impact factor: 7.842

3.  Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution.

Authors:  Angela Chou; Ondrej Hes; John Turchini; Kiril Trpkov; Anthony J Gill
Journal:  Mod Pathol       Date:  2017-10       Impact factor: 7.842

4.  Reply to Lambros et al.

Authors:  Zhenya Tang; Jianjun Zhang; Hui Chen; Selina Lu; Joanne Cheng; Guilin Tang; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2018-03       Impact factor: 7.842

Review 5.  Diagnostic and Prognostic Utility of Fluorescence In situ Hybridization (FISH) Analysis in Acute Myeloid Leukemia.

Authors:  Patrick R Gonzales; Fady M Mikhail
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

6.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

7.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  Arch Pathol Lab Med       Date:  2013-04-03       Impact factor: 5.534

8.  Standardization and optimization of fluorescence in situ hybridization (FISH) for HER-2 assessment in breast cancer: A single center experience.

Authors:  Magdalena Bogdanovska-Todorovska; Gordana Petrushevska; Vesna Janevska; Liljana Spasevska; Slavica Kostadinova-Kunovska
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

Review 9.  Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections.

Authors:  Maisa Yoshimoto; Olga Ludkovski; Jennifer Good; Ciro Pereira; Robert J Gooding; Jean McGowan-Jordan; Alexander Boag; Andrew Evans; Ming-Sound Tsao; Paulo Nuin; Jeremy A Squire
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

10.  Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Athena M Cherry; Yassmine M Akkari; Kimberly M Barr; Hutton M Kearney; Nancy C Rose; Sarah T South; James H Tepperberg; Jeanne M Meck
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.